Skip to main content
Genome Announcements logoLink to Genome Announcements
. 2014 Mar 6;2(2):e00162-14. doi: 10.1128/genomeA.00162-14

Draft Genome Sequence of a Methicillin-Resistant Staphylococcus aureus ST1413 Strain for Studying Genetic Mechanisms of Antibiotic Resistance

Bernard S Marasa a, Javier Revollo b, Saira Iram d, Kidon Sung a, Joshua Xu c, Saeed Khan a,
PMCID: PMC3945512  PMID: 24604656

Abstract

Here we report the whole draft genome sequence of a methicillin-resistant Staphylococcus aureus ST1413 strain. Determining the distribution and arrangement of various genes associated with drug resistance, toxicity, and diseases will enhance our understanding about its adaptability to thrive in different ecological niches and help in the development of effective treatments for enterotoxigenic staphylococcal infections.

GENOME ANNOUNCEMENT

Staphylococcus aureus remains one of the most important bacterial pathogens due to its high virulence and capability to cause multiple ailments ranging from complicated skin and skin structure infections to life-threatening conditions, such as endocarditis, pneumonia, and toxic shock syndrome (1, 2). S. aureus isolates involved in community-acquired and nosocomial infections often exhibit resistance to multiple antibiotics, including macrolides, aminoglycosides, fluoroquinolones, methicillin, and vancomycin (36), and pose serious challenges to treatment options. A combination of antimicrobial agents is often used to improve survival of the patients (79). This leads to the selection, transmission, and persistence of multidrug resistance traits in S. aureus. The presence of antimicrobial resistance with a wide range of enterotoxin and virulence genes makes S. aureus a highly pathogenic and difficult-to-treat organism. Its chromosome is reported to contain ~22% dispensable genetic material, with several regions showing large areas of genetic differences, some of which carry the genes for virulence factors, toxins, and antimicrobial resistance (10). These variations in the gene content are probably responsible for poorly understood phenomena of disease and host specificity and warrant a need to understand the genetics of S. aureus development and evolution. Here we report the draft genome sequence of the S. aureus ST1413 strain named 10S (sequence type [ST] 1413 and spa type t314), with approximately 2.78 million bp and 2,902 genes, 4 rRNAs, 49 tRNAs, and 1 noncoding RNA (ncRNA). S. aureus ST1413 lacked any detectable plasmids but was positive for staphylococcal cassette chromosome mec type II (SCC mec II), III, and V genes. It was resistant to ampicillin, tetracycline, penicillin, gentamicin, ciprofloxacin, and methicillin but sensitive to erythromycin and vancomycin and harbored toxin genes (eta, sea, seb, sec, sei, sej, hla, hlb, hld, hlg, pvl, sed, see, seg, seh, and tst), adhesin genes (ebpS, bbp, can, clfA, clfB, fnbA, fnbB, map-eap, and spa), and virulence genes (ica, cfb, and v8). Determination of the arrangement of these elements in the genome, along with their locations and genetic distributions, and comparative analyses among virulent and avirulent isolates could be extremely helpful in understanding the genetic evolution and development of effective therapeutic interventions for S. aureus infections.

The extraction of genomic DNA was done using a Master Pure Gram-positive DNA purification kit (Epicentre Biotechnologies). The preparation of a library, emPCR, and sequencing were performed using the GS Junior Titanium Series protocols per the manufacturer’s instructions. To prepare the library, 500 ng of genomic DNA was sheared by nebulization to obtain DNA fragments smaller than 1,000 bp. These fragments were end-repaired and ligated to Rapid Library adaptors. The library was quantitated by a fluorometer, diluted to 1 × 107 molecules/μl, and used as a template for emPCR amplification. The DNA-coated beads were then primed and loaded onto a GS Junior with all the necessary sequencing reagents. A single GS Junior run generated 49,256,106 bases in 131,242 reads. The data from the run were then assembled into 327 contigs covering 2,780,250 bases by the GS De Novo Assembler version 2.7 under default settings. Annotation was performed with the NCBI Prokaryotic Genomes Automatic Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.html).

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number AYXU00000000. The version described in this paper is version AYXU01000000.

ACKNOWLEDGMENTS

The work was supported by intramural funding by the U.S. Food and Drug Administration (protocol E07515.01).

We thank Bridgett Green and Baitang Ning of the Division of Systems Biology, National Center for Toxicological Research, FDA, for their assistance with the Roche 454 system.

Views presented in this paper do not necessarily reflect those of the FDA.

Footnotes

Citation Marasa BS, Revollo J, Iram S, Sung K, Xu J, Khan S. 2014. Draft genome sequence of a methicillin-resistant Staphylococcus aureus ST1413 strain for studying genetic mechanisms of antibiotic resistance. Genome Announc. 2(2):e00162-14. doi:10.1128/genomeA.00162-14.

REFERENCES

  • 1. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520–532. 10.1056/NEJM199808203390806 [DOI] [PubMed] [Google Scholar]
  • 2. Gordon RJ, Lowy FD. 2008. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46(Suppl 5):S350–S359. 10.1086/533591 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. de Lencastre H, Oliveira D, Tomasz A. 2007. Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr. Opin. Microbiol. 10:428–435. 10.1016/j.mib.2007.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Rosenberg J. 1995. Methicillin-resistant Staphylococcus aureus (MRSA) in the community: who’s watching? Lancet 346:132–133. 10.1016/S0140-6736(95)91203-7 [DOI] [PubMed] [Google Scholar]
  • 5. Berger-Bächi B, Rohrer S. 2002. Factors influencing methicillin resistance in staphylococci. Arch. Microbiol. 178:165–171. 10.1007/s00203-002-0436-0 [DOI] [PubMed] [Google Scholar]
  • 6. Mwangi MM, Wu SW, Zhou Y, Sieradzki K, de Lencastre H, Richardson P, Bruce D, Rubin E, Myers E, Siggia ED, Tomasz A. 2007. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. U. S. A. 104:9451–9456. 10.1073/pnas.0609839104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. 2001. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J. Clin. Microbiol. 39:3727–3732. 10.1128/JCM.39.10.3727-3732.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Eliopoulos GM. 1989. Synergism and antagonism. Infect. Dis. Clin. North Am. 3:399–406 [PubMed] [Google Scholar]
  • 9. Alvarez-Lerma F. 1996. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med. 22:387–394. 10.1007/BF01712153 [DOI] [PubMed] [Google Scholar]
  • 10. Fitzgerald JR, Musser JM. 2001. Evolutionary genomics of pathogenic bacteria. Trends Microbiol. 9:547–553. 10.1016/S0966-842X(01)02228-4 [DOI] [PubMed] [Google Scholar]

Articles from Genome Announcements are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES